- Home
- PTGX vs MSGS Comparison
PTGX vs MSGS Comparison
Compare PTGX & MSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | MSGS |
|---|---|---|
| Founded | 2006 | 1879 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.4B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTGX | MSGS |
|---|---|---|
| Price | $89.29 | $226.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $86.44 | ★ $260.50 |
| AVG Volume (30 Days) | ★ 886.1K | 146.2K |
| Earning Date | 11-06-2025 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | $209,217,000.00 | ★ $1,025,367,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $296.47 | $4.61 |
| P/E Ratio | $124.09 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $33.70 | $173.26 |
| 52 Week High | $93.25 | $237.99 |
Technical Indicators
Market Signals| Indicator | PTGX | MSGS |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 58.64 |
| Support Level | $83.52 | $219.00 |
| Resistance Level | $90.85 | $226.55 |
| Average True Range (ATR) | 2.63 | 4.62 |
| MACD | -0.33 | 0.77 |
| Stochastic Oscillator | 83.62 | 85.09 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About MSGS Madison Square Garden Sports Corp. (New)
Madison Square Garden Sports Corp owns and operates a portfolio of assets featuring some of the recognized sports teams, including the Knicks of the NBA and the Rangers of the NHL. It generates revenue from several sources: ticket sales and a portion of suite rental fees at The Garden and others. It has one operating and reportable segment and one reporting unit for goodwill impairment testing purposes.